Clinical Trial Update: Sorafenib Plus Capecitabine Efficacy Assessment in Patients With Advanced Pre-treated Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy of combining sorafenib with capecitabine in patients with advanced pre-treated colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Nexavar (Sorafenib)
• Xeloda (capecitabine)

Snippet

Sponsor: Jules Bordet Institute | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED